Gsk (GLAXF) EPS (Basic) (2009 - 2026)

Gsk (GLAXF) recorded quarterly EPS (Basic) of $0.0 in Q1 2026, up 173.11% quarter-over-quarter from $0.0 in Q4 2025, and up 6.96% on a YoY basis from $0.0 in Q1 2025.

Gsk (GLAXF) EPS (Basic) (2009 - 2026) Analysis & Trends

Gsk's EPS (Basic) history runs 18 years deep, the most recent figure standing at $0.0 for Q1 2026.

  • In Q1 2026, EPS (Basic) rose 6.96% year-over-year to $0.0; the TTM figure through Mar 2026 stood at $0.0 (down 100.0% YoY), while the FY2025 annual figure was $1.86, up 130.29% from the prior year.
  • EPS (Basic) was $0.0 for Q1 2026 at Gsk, up from $0.0 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $3.71 in Q4 2022 to a low of -$0.0 in Q3 2024.
  • Historically, EPS (Basic) has averaged $0.36 across 5 years, with a median of $0.0 in 2025.
  • The sharpest annual moves came in 2024 and 2025: EPS (Basic) slumped 103.96% in 2024, then jumped 3568.12% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at $3.71 in 2022, then plunged by 79.31% to $0.77 in 2023, then surged by 114.2% to $1.65 in 2024, then tumbled by 100.0% to $0.0 in 2025, then jumped by 173.11% to $0.0 in 2026.
  • The last three EPS (Basic) figures came in at $0.0 (Q1 2026), $0.0 (Q4 2025), and $0.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 0.00
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 8.27
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 2.17
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 0.39
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -1.72
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 3.37
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.63
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 0.48
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 1.31
10 Gsk - - 7.76 Bn 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 1.65
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.77
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 3.71
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.19
Sep 30, 2021 0.00
Jun 30, 2021 0.00